3-52392973-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_015512.5(DNAH1):​c.10422T>C​(p.Leu3474Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00559 in 1,613,646 control chromosomes in the GnomAD database, including 69 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 4 hom., cov: 31)
Exomes 𝑓: 0.0058 ( 65 hom. )

Consequence

DNAH1
NM_015512.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.40

Publications

3 publications found
Variant links:
Genes affected
DNAH1 (HGNC:2940): (dynein axonemal heavy chain 1) This gene encodes an inner dynein arm heavy chain that provides structural support between the radial spokes and the outer doublet of the sperm tail. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and multiple morphological anomalies of the flagella that result in asthenozoospermia and male infertility. Mice with a homozygous knockout of the orthologous gene are viable but have reduced sperm motility and are infertile. [provided by RefSeq, Feb 2017]
DNAH1 Gene-Disease associations (from GenCC):
  • spermatogenic failure 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • ciliary dyskinesia, primary, 37
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 3-52392973-T-C is Benign according to our data. Variant chr3-52392973-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 478383.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.4 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00374 (569/151986) while in subpopulation SAS AF = 0.0231 (111/4800). AF 95% confidence interval is 0.0196. There are 4 homozygotes in GnomAd4. There are 287 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH1NM_015512.5 linkc.10422T>C p.Leu3474Leu synonymous_variant Exon 65 of 78 ENST00000420323.7 NP_056327.4
DNAH1XM_017006129.2 linkc.10491T>C p.Leu3497Leu synonymous_variant Exon 67 of 80 XP_016861618.1
DNAH1XM_017006130.2 linkc.10422T>C p.Leu3474Leu synonymous_variant Exon 66 of 79 XP_016861619.1
DNAH1XM_017006131.2 linkc.10365T>C p.Leu3455Leu synonymous_variant Exon 66 of 79 XP_016861620.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH1ENST00000420323.7 linkc.10422T>C p.Leu3474Leu synonymous_variant Exon 65 of 78 1 NM_015512.5 ENSP00000401514.2
DNAH1ENST00000486752.5 linkn.10879T>C non_coding_transcript_exon_variant Exon 64 of 77 2
DNAH1ENST00000488988.5 linkn.2208T>C non_coding_transcript_exon_variant Exon 12 of 25 2
DNAH1ENST00000490713.5 linkn.1122T>C non_coding_transcript_exon_variant Exon 8 of 20 5 ENSP00000419071.1

Frequencies

GnomAD3 genomes
AF:
0.00375
AC:
570
AN:
151868
Hom.:
4
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000920
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00308
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00424
Gnomad SAS
AF:
0.0233
Gnomad FIN
AF:
0.00142
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00475
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00567
AC:
1412
AN:
249216
AF XY:
0.00670
show subpopulations
Gnomad AFR exome
AF:
0.000904
Gnomad AMR exome
AF:
0.00238
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.00367
Gnomad FIN exome
AF:
0.00158
Gnomad NFE exome
AF:
0.00418
Gnomad OTH exome
AF:
0.00281
GnomAD4 exome
AF:
0.00579
AC:
8458
AN:
1461660
Hom.:
65
Cov.:
38
AF XY:
0.00632
AC XY:
4598
AN XY:
727108
show subpopulations
African (AFR)
AF:
0.000717
AC:
24
AN:
33478
American (AMR)
AF:
0.00224
AC:
100
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00161
AC:
42
AN:
26134
East Asian (EAS)
AF:
0.00380
AC:
151
AN:
39696
South Asian (SAS)
AF:
0.0233
AC:
2007
AN:
86254
European-Finnish (FIN)
AF:
0.00152
AC:
81
AN:
53384
Middle Eastern (MID)
AF:
0.00520
AC:
30
AN:
5768
European-Non Finnish (NFE)
AF:
0.00511
AC:
5678
AN:
1111852
Other (OTH)
AF:
0.00571
AC:
345
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
515
1030
1544
2059
2574
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00374
AC:
569
AN:
151986
Hom.:
4
Cov.:
31
AF XY:
0.00386
AC XY:
287
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.000917
AC:
38
AN:
41422
American (AMR)
AF:
0.00308
AC:
47
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3470
East Asian (EAS)
AF:
0.00425
AC:
22
AN:
5174
South Asian (SAS)
AF:
0.0231
AC:
111
AN:
4800
European-Finnish (FIN)
AF:
0.00142
AC:
15
AN:
10580
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00474
AC:
322
AN:
67960
Other (OTH)
AF:
0.00284
AC:
6
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
30
60
91
121
151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00393
Hom.:
11
Bravo
AF:
0.00292
Asia WGS
AF:
0.00837
AC:
29
AN:
3478
EpiCase
AF:
0.00403
EpiControl
AF:
0.00504

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 09, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 20, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
3.0
DANN
Benign
0.71
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148913561; hg19: chr3-52426989; COSMIC: COSV107515692; COSMIC: COSV107515692; API